MGX

Metagenomi Therapeutics Inc

Jun 15 • 04:00PM ET

1.17

-0.03 -2.50 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: BYSI CING ESLA IBIO IBO IMA IMMP PDSB TIL GOSS

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.29	Insider Own	22.55%	Shs Outstand	37.65M	Perf Week	-9.30%
Market Cap	44.05M	Forward P/E	-	EPS next Y	-1.57	Insider Trans	-0.13%	Shs Float	29.16M	Perf Month	-13.33%
Enterprise Value	-56.92M	PEG	-	EPS next Q	-0.58	Inst Own	17.44%	Short Float	6.28%	Perf Quarter	-20.95%
Income	-85.89M	P/S	1.97	EPS this Y	10.01%	Inst Trans	-1.95%	Short Ratio	9.94	Perf Half Y	-32.76%
Sales	22.33M	P/B	0.32	EPS next Y	26.30%	ROA	-34.71%	Short Interest	1.83M	Perf YTD	-27.78%
Book/sh	3.66	P/C	0.31	EPS next 5Y	2.65%	ROE	-49.02%	52W High	3.95 -70.38%	Perf Year	-18.18%
Cash/sh	3.72	P/FCF	-	EPS past 3/5Y	-26.57% -42.49%	ROIC	-50.27%	52W Low	1.20 -2.50%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	13.59% 219.15%	Gross Margin	76.56%	Volatility	4.40% 4.95%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-2.55	EPS Y/Y TTM	-9.30%	Oper. Margin	-415.48%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.43	Sales Y/Y TTM	-50.66%	Profit Margin	-384.61%	RSI (14)	31.44	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	6.43	EPS Q/Q	9.28%	SMA20	-9.62%	Beta	0.70	Target Price	8.00
Payout	-	Debt/Eq	0.28	Sales Q/Q	-69.76%	SMA50	-14.30%	Rel Volume	1.77	Prev Close	1.20
Employees	119	LT Debt/Eq	0.24	Earnings	May 11 AMC	SMA200	-33.15%	Avg Volume	184.17K	Price	1.17
IPO	Feb 09, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-10.23% -78.86%	Trades		Volume	326,829	Change	-2.50%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)